SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-22-016892
Filing Date
2022-09-15
Accepted
2022-09-15 17:13:30
Documents
12
Period of Report
2022-09-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K organicell_8-k.htm   iXBRL 8-K 24214
  Complete submission text file 0001829126-22-016892.txt   190806

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bpsr-20220913.xsd EX-101.SCH 2965
3 XBRL LABEL FILE bpsr-20220913_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE bpsr-20220913_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT organicell_8-k_htm.xml XML 3295
Mailing Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140
Business Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 221246437
SIC: 3790 Miscellaneous Transportation Equipment